Alnylam Pharmaceuticals ALNY
NASDAQ ALNY
$255.36 -0.60 (-0.23%)
At close: Sep 28, 2026 · 4:00 PM EDT

Alnylam Pharmaceuticals (ALNY) Operating Leases (2019 - 2026)

Updated

Alnylam Pharmaceuticals (ALNY) posted Operating Leases of $210.5 million for Q2 2026, down 6.2% from $224.45 million a year earlier and down 3.5% from the prior quarter.

Analysis

Alnylam Pharmaceuticals (ALNY) Operating Leases (2019 - 2026) Analysis & Trends

At the end of FY2025, Alnylam Pharmaceuticals' Operating Leases came in at $225.09 million, down 1.9% from FY2024.

  • Annual Operating Leases has declined for five consecutive years, with a five-year compound annual growth rate of -5.1% (FY2020 to FY2025).
  • In prior years, Alnylam Pharmaceuticals' Operating Leases was $229.54 million in FY2024 (-5.6%), $243.1 million in FY2023 (-7.0%), $261.34 million in FY2022 (-7.1%) and $281.35 million in FY2021 (-4.0%).
  • The Q2 2026 figure stands as the lowest quarterly Operating Leases in data going back to Q1 2019.
  • On a year-over-year basis, Operating Leases has declined in each of the last 20 quarters, with an average decline of 4.8% over the last eight quarters.
  • The year-over-year decline in Operating Leases has ranged between 1.9% (Q4 2025) and 8.3% (Q1 2024) over the last five years.
  • According to Business Quant data, Operating Leases for the three prior quarters was $218.03 million (Q1 2026), $225.09 million (Q4 2025) and $223.42 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn
10 Alnylam Pharmaceuticals 34.23 Bn 22.28 Bn 992.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 210.50 Mn
Mar 31, 2026 218.03 Mn
Dec 31, 2025 225.09 Mn
Sep 30, 2025 223.42 Mn
Jun 30, 2025 224.45 Mn
Mar 31, 2025 230.06 Mn
Dec 31, 2024 229.54 Mn
Sep 30, 2024 236.03 Mn
Jun 30, 2024 239.35 Mn
Mar 31, 2024 237.83 Mn
Dec 31, 2023 243.10 Mn
Sep 30, 2023 247.71 Mn
Jun 30, 2023 253.42 Mn
Mar 31, 2023 259.40 Mn
Dec 31, 2022 261.34 Mn
Sep 30, 2022 266.32 Mn
Jun 30, 2022 272.02 Mn
Mar 31, 2022 277.39 Mn
Dec 31, 2021 281.35 Mn
Sep 30, 2021 286.03 Mn
API Access

Alnylam Pharmaceuticals Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=ALNY&period=max&api_key=YOUR_API_KEY